HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Clinical trials for HEPATOCELLULAR CARCINOMA NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA NON-RESECTABLE trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink untreatable liver tumors
Disease control Recruiting nowThis study tests whether adding two immunotherapy drugs (durvalumab and tremelimumab) to a radiation bead treatment (Y-90 SIRT) can shrink liver tumors that cannot be surgically removed. About 55 adults with intermediate-stage liver cancer will receive the combination. The main g…
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 26, 2026 09:19 UTC
-
Proton beam plus immunotherapy shows promise against tough liver tumors
Disease control Recruiting nowThis study tests whether adding proton radiotherapy to standard immunotherapy (atezolizumab and bevacizumab) can better control advanced liver cancer that cannot be removed by surgery. About 45 adults with unresectable hepatocellular carcinoma will receive the combination therapy…
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New combo therapy aims to stop liver cancer from growing back
Disease control Recruiting nowThis study tests whether adding a precise, high-dose radiation treatment (SBRT) after a standard liver cancer procedure (TACE) can better control tumors that cannot be surgically removed. About 30 adults with early- to intermediate-stage liver cancer will receive the combination …
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: NA • Sponsor: RWTH Aachen University • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New combo attack on tough liver cancer: radiation beads then immunotherapy
Disease control Recruiting nowThis study tests a two-step treatment for people with advanced liver cancer that has spread into the main liver vein (portal vein thrombosis). First, tiny radioactive beads are injected into the liver to shrink the tumor from inside. Then, two immunotherapy drugs are given to hel…
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Center Eugene Marquis • Aim: Disease control
Last updated May 22, 2026 13:51 UTC